Technical Analysis for JAZZ - Jazz Pharmaceuticals plc

Grade Last Price % Change Price Change
grade C 136.82 0.23% 0.32
JAZZ closed up 0.23 percent on Wednesday, June 26, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical JAZZ trend table...

Date Alert Name Type % Chg
Doji - Bearish? Reversal 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 50 DMA Bullish 0.23%
MACD Bullish Centerline Cross Bullish 0.23%
180 Bullish Setup Bullish Swing Setup 0.23%
Expansion Pivot Buy Setup Bullish Swing Setup 0.23%
Wide Range Bar Range Expansion 0.23%
Above Upper BB Strength 0.23%
Upper Bollinger Band Touch Strength 0.23%
Fell Below 50 DMA Bearish 4.20%

Older signals for JAZZ ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products for various medical needs in the United States, Europe, and other countries. The company's products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Erwinaze to treat acute lymphoblastic leukemia; Prialt for the management of severe chronic pain; and FazaClo LD and FazaClo HD, which are orally disintegrating clozapine tablets for the resistant schizophrenia treatment. It also provides Luvox CR to treat obsessive compulsive disorder; Versacloz oral suspension; Caphosol to treat oral mucositis; Quadramet for the treatment of pain in patients whose cancer has spread to the bones; ProstaScint for imaging the extent and spread of prostate cancer; Niravam for the treatment of generalized anxiety and panic disorders; and Parcopa for the symptoms associated with idiopathic Parkinson's disease treatment. In addition, the company offers Collatamp, a surgical implant impregnated with the antibiotic gentamicin; Fomepizole to treat ethylene glycol poisoning; Kidrolase for treating ALL, Leukaemic meningitis, and non-Hodgkin's lymphoma; Xenazine to treat movement disorders associated with Huntington's chorea and hemiballismus; and Custodiol, a ready to use solution used in organ transplantation. Further, it develops Asparec, a pegylated recombinant Erwinia asparaginase that is in Phase I clinical trials for the treatment of patients with ALL with E. coli asparaginase hypersensitivity; and Leukotac, an anti-CD25 monoclonal antibody is in Phase III clinical trials for the treatment of steroid-refractory acute graft vs. host diseases. The company markets its products through its sales representatives, distributors, and wholesalers, as well as through third party vendors. Jazz Pharmaceuticals Public Limited Company is headquartered in Dublin, Ireland.
Medicine Biotechnology Biopharmaceutical Cancer Clinical Medicine Pain Drugs Imaging Pharmaceutical Products Prostate Cancer Lymphoma Pharmacokinetics Transplantation Movement Disorders Obsessive Compulsive Disorder Severe Chronic Pain Acute Lymphoblastic Leukemia Oral Hygiene Pegylation Asparaginase Host Diseases Narcolepsy
Is JAZZ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 181.46
52 Week Low 113.52
Average Volume 491,770
200-Day Moving Average 139.7697
50-Day Moving Average 132.6946
20-Day Moving Average 130.864
10-Day Moving Average 133.011
Average True Range 3.7243
ADX 13.88
+DI 24.2423
-DI 19.7782
Chandelier Exit (Long, 3 ATRs ) 127.1671
Chandelier Exit (Short, 3 ATRs ) 135.2629
Upper Bollinger Band 136.9112
Lower Bollinger Band 124.8168
Percent B (%b) 0.99
BandWidth 9.241961
MACD Line 0.4537
MACD Signal Line -0.4088
MACD Histogram 0.8625
Fundamentals Value
Market Cap 8.22 Billion
Num Shares 60.1 Million
EPS 6.49
Price-to-Earnings (P/E) Ratio 21.08
Price-to-Sales 5.40
Price-to-Book 3.78
PEG Ratio 0.72
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 142.16
Resistance 3 (R3) 142.07 140.21 141.27
Resistance 2 (R2) 140.21 138.85 140.25 140.97
Resistance 1 (R1) 138.51 138.01 137.58 138.60 140.68
Pivot Point 136.65 136.65 136.18 136.69 136.65
Support 1 (S1) 134.95 135.29 134.02 135.04 132.96
Support 2 (S2) 133.09 134.45 133.13 132.67
Support 3 (S3) 131.39 133.09 132.37
Support 4 (S4) 131.48